BrightSpring Health Services (BTSG) Cash & Equivalents (2023 - 2026)

BrightSpring Health Services has reported Cash & Equivalents for 4 years, with the latest figure at $888.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 1598.22% year-over-year to $888.8 million; the trailing twelve-month figure through Mar 2026 stood at $888.8 million (up 1598.22% YoY), and the FY2025 full-year result was $88.4 million, up 44.98% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $888.8 million, up from $88.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $888.8 million in Q1 2026, with the low at $13.1 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $143.3 million across 4 years, with a median of $59.5 million in 2024.
• Annual changes were most pronounced in 2025 — Cash & Equivalents slipped 9.82% — and 2026, when it surged 1598.22%.
• BrightSpring Health Services' Cash & Equivalents stood at $13.1 million in 2023, then surged by 366.33% to $61.0 million in 2024, then soared by 44.98% to $88.4 million in 2025, then soared by 905.77% to $888.8 million in 2026.
• The last three Cash & Equivalents figures came in at $888.8 million (Q1 2026), $88.4 million (Q4 2025), and $140.3 million (Q3 2025), per Business Quant data.